JP2000227399A - Preliminary screening device of blood test body - Google Patents

Preliminary screening device of blood test body

Info

Publication number
JP2000227399A
JP2000227399A JP11028906A JP2890699A JP2000227399A JP 2000227399 A JP2000227399 A JP 2000227399A JP 11028906 A JP11028906 A JP 11028906A JP 2890699 A JP2890699 A JP 2890699A JP 2000227399 A JP2000227399 A JP 2000227399A
Authority
JP
Japan
Prior art keywords
blood test
ccd camera
processing circuit
output
judgment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11028906A
Other languages
Japanese (ja)
Inventor
Kazunori Uryo
一紀 有涼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PKD KK
Original Assignee
PKD KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PKD KK filed Critical PKD KK
Priority to JP11028906A priority Critical patent/JP2000227399A/en
Publication of JP2000227399A publication Critical patent/JP2000227399A/en
Pending legal-status Critical Current

Links

Landscapes

  • Spectrometry And Color Measurement (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)

Abstract

PROBLEM TO BE SOLVED: To improve the efficiency in this type of analysis by eliminating the need for highly advance experience and a certain degree of judgment for simplification and reducing the number of inspection personnel although they have been required for conventional judgment by viewing. SOLUTION: A preliminary screening device 1 consists of a light source 2 for emitting a wavelength at least in a visible light range, a CCD camera 3 of the three primary colors of RGB for applying light that is emitted from the light source and is passed through a blood test body 10, a processing circuit 4 for numerically changing the output of the CCD camera 3 to an appropriate bit scale corresponding to accuracy required for each of the three primary colors, and a judgment circuit for judging whether the inspection of the blood test body is appropriate or not according to the output of the processing circuit 4, thus totally eliminating the need for highly advance experience and a certain degree of judgment although they have been required for a conventional judgment by viewing.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は健康検診あるいは病
気の診断などを行うときに一環として行われる血液検査
に関するものであり、詳細には、分析結果の精度を確保
するために、血液の検査を行うのに先立って、分析に有
害な物質が混入していないことを確認するために行われ
る予備検査に係るものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a blood test performed as a part of a health checkup or a disease diagnosis, and more particularly, to a blood test in order to ensure the accuracy of analysis results. Prior to conducting the test, it is a preliminary test performed to confirm that no harmful substances have been mixed in the analysis.

【0002】[0002]

【従来の技術】血液検査を行う際には血液中に検査結果
に重大な影響を与える乳び、溶血ヘモグロビン、ビリル
ビンなどの混入がないかを予めに確認する予備検査を行
う必要があり、この検査は従来、練達の臨床検査技師に
より、分析装置にかける前に目視により行われ、検査結
果に影響を与える混入程度以上と判断されたものが除外
されるものであった。
2. Description of the Related Art When performing a blood test, it is necessary to perform a preliminary test to confirm in advance whether blood contains chyle, hemolyzed hemoglobin, bilirubin, etc., which have a significant effect on the test result. Inspection has conventionally been carried out visually by a trained clinical laboratory technician before being applied to an analyzer, and those which have been judged to be at least the degree of contamination affecting the test results have been excluded.

【0003】[0003]

【発明が解決しようとする課題】しかしながら、上記し
た現状では、予備検査を行う検査技師などの経験に基づ
くものであるので確固たる基準がなく、当日の担当者の
相違など個人差などにより判定基準にブレを生じること
は避け難く、また、担当者が同一である場合でも体調あ
るいは時間の経過などにより判定基準にブレを生じるこ
ともあり得るものとなる。
However, in the above-mentioned current situation, there is no firm standard because it is based on the experience of a laboratory technician who performs a preliminary inspection. It is inevitable that blurring occurs, and even when the same person in charge is used, blurring may occur in the determination criterion due to physical condition or the passage of time.

【0004】ここで、予備検査で検査に不適と判定され
ると、医療現場では再度採血して検査体を再入手しなけ
れば成らず、大変に煩雑なものとなるので、判定は可能
な限りに基準に対して正確かつブレがないことが要求さ
れるものであるが、上記の判定の現状では要求を満足さ
せるには至らないものである。
[0004] Here, if the preliminary examination determines that the specimen is unsuitable for the examination, it is necessary to collect blood again at the medical site and obtain the specimen again, which is very complicated. Although it is required that the standard is accurate and has no blur, the above-described determination does not satisfy the requirement.

【0005】尚、上記の問題を解決するために、上記の
乳び、溶血ヘモグロビン、ビリルビンのそれぞれが有す
る特有の吸収スペクトルを利用し、検査体に対して複数
の所定波長における吸光度を測定し、上記それぞれの不
純物の混和率の測定を行う手段も提案されているが、こ
の場合には、例えば6波長に対して測定の必要を生じる
など装置自体が煩雑化する問題点を生じる。
[0005] In order to solve the above-mentioned problem, the absorbance at a plurality of predetermined wavelengths is measured with respect to the test object by utilizing the specific absorption spectra of the above chyle, hemolyzed hemoglobin and bilirubin, respectively. Means for measuring the mixing ratio of each of the above-mentioned impurities has also been proposed. However, in this case, there is a problem that the apparatus itself becomes complicated, for example, measurement is required for six wavelengths.

【0006】[0006]

【課題を解決するための手段】本発明は前記した従来の
課題を解決するための具体的手段として、予備選別装置
は、少なくとも可視光範囲の波長を放射する光源と、前
記光源から放射され前記血液検査体を透過した光を入射
させるRGB三原色のCCDカメラと、前記CCDカメ
ラの出力をそれぞれの原色ごとに要求される精度に応じ
る適宜ビットスケールに数値化する処理回路と、前記処
理回路の出力により当該の血液検査体の検査の可否を判
定する判定回路とから成ることを特徴とする血液検査体
の予備選別装置を提供することで課題を解決するもので
ある。
According to the present invention, as a specific means for solving the above-mentioned conventional problems, a preselection device comprises a light source emitting at least a wavelength in a visible light range, and a light source emitted from the light source. A RGB primary color CCD camera for receiving light transmitted through the blood test object, a processing circuit for digitizing the output of the CCD camera into an appropriate bit scale according to the precision required for each primary color, and an output of the processing circuit The present invention solves the problem by providing a preselection device for a blood test object, which comprises a determination circuit for determining whether or not the blood test object can be tested.

【0007】[0007]

【発明の実施の形態】つぎに、本発明を図に示す実施形
態に基づいて詳細に説明する。図1に符号1で示すもの
は本発明に係る血液検査体の予備選別装置であり、この
予備選別装置1は光源2とCCDカメラ3と処理回路4
と判定回路5と表示器6とから構成されている。
Next, the present invention will be described in detail based on an embodiment shown in the drawings. The reference numeral 1 shown in FIG. 1 is a preselection apparatus for a blood test object according to the present invention, which comprises a light source 2, a CCD camera 3, and a processing circuit 4.
And a decision circuit 5 and a display 6.

【0008】また、図中に符号10で示すものは試験管
など適宜な透明容器11に入れられた血液などの検査体
である。尚、いうまでもないが、前記検査体10は、遠
心分離機による固形分の分離など検査に必要な処理が既
に行われている状態のものである。
In the drawing, reference numeral 10 denotes a test object such as blood put in an appropriate transparent container 11 such as a test tube. Needless to say, the test object 10 is in a state where processing required for inspection such as separation of solids by a centrifuge has already been performed.

【0009】本発明では、前記光源2としては、例えば
白熱電球、ハロゲン電球あるいはキセノンランプなど、
いわゆる白色発光で且つ市場で簡便に入手可能なものが
採用され、従来例でも説明した吸光分析を行うときに採
用されていた単色光の光源などに比較して大幅な簡素化
が行われている。
In the present invention, the light source 2 is, for example, an incandescent lamp, a halogen lamp, a xenon lamp, or the like.
What is called white light emission and easily available in the market is adopted, and the simplification is greatly simplified as compared with the monochromatic light source used when performing the absorption analysis described in the conventional example. .

【0010】また、本発明で採用されるCCDカメラ3
はR(赤)、G(緑)、B(青)三原色のものであり、
後にも説明するが、本発明の予備選別装置1ではいわゆ
る画像処理を行うものではないので、例えば前記透明容
器11の形状、あるいは、透明容器11とCCDカメラ
3との距離などを適正化すれば、CCDカメラ3として
はCCD素子のみでも実施は可能である。
[0010] The CCD camera 3 employed in the present invention.
Are the three primary colors of R (red), G (green), and B (blue),
As will be described later, since the preselection apparatus 1 of the present invention does not perform so-called image processing, for example, if the shape of the transparent container 11 or the distance between the transparent container 11 and the CCD camera 3 is optimized. The embodiment can be implemented by using only the CCD element as the CCD camera 3.

【0011】前記処理回路4は前記CCDカメラ3から
の出力を処理するものであり、機能としては、先ず、
R、G、Bの各色毎の処理が行われ、そして各色毎の処
理の後に総合した処理が行われ、その結果が前記判定回
路5で判定され、この判定結果が例えば赤色と緑色の2
つのランプなど、適宜な表示器6に出力されるものであ
る。
The processing circuit 4 processes the output from the CCD camera 3. The function of the processing circuit 4 is as follows.
The processing for each of the colors R, G, and B is performed, and the integrated processing is performed after the processing for each of the colors. The determination result is determined by the determination circuit 5.
It is output to an appropriate display 6 such as one lamp.

【0012】図2は前記処理回路4の機能を模式的に示
す説明図であり、最初の処理として前記CCDカメラ3
からのR、G、B別の出力の強度(=輝度)をそれぞ
れ、例えば前記透明容器11に純水を入れたときを基準
とする8ビットスケール(256階調)として2値化す
る。
FIG. 2 is an explanatory diagram schematically showing the function of the processing circuit 4. The CCD camera 3 is used as a first process.
The intensity (= brightness) of each output of R, G, and B is binarized, for example, as an 8-bit scale (256 gradations) based on pure water in the transparent container 11.

【0013】従って、上記の2値化が行われた時点で、
前記CCDカメラ3からの出力からは、R(256階
調)×G(256階調)×B(256階調)による16
777216通りの色の組合せ中の1色が得られるもの
となるのである。尚、上記した2値化を行うときの8ビ
ットスケールは1例であり、予備選別装置1に要求され
る精度を考慮し、例えば6ビットスケール(約26万
色)あるいは10ビットスケール(約11億色)などと
変更するのは自在である。
Therefore, when the above-mentioned binarization is performed,
From the output from the CCD camera 3, 16 (R (256 tones) × G (256 tones) × B (256 tones))
One color out of the 777216 color combinations is obtained. Note that the 8-bit scale when performing the above-described binarization is an example, and in consideration of the accuracy required for the preliminary selection device 1, for example, a 6-bit scale (about 260,000 colors) or a 10-bit scale (about 11 It is possible to change it to "billion colors".

【0014】このようにしたことで、CCDカメラ3か
らの出力から約1677万色(8ビットスケールの場
合)の識別が可能となる。ここで、血液検査時において
検査値に影響を与えるとされている乳び、溶血ヘモグロ
ビン、ビリルビンについて検討を行うと、前記した乳び
においては図3に示すように、やや短波長側が吸収量が
多い全波長に渡る波長吸収特性Nを有していることが知
られている。
By doing so, it is possible to identify about 16.77 million colors (in the case of an 8-bit scale) from the output from the CCD camera 3. Here, when examining chyle, hemolyzed hemoglobin, and bilirubin, which are considered to affect the test value at the time of a blood test, as shown in FIG. It is known to have a wavelength absorption characteristic N over a large number of all wavelengths.

【0015】即ち、検査体10中に乳びが混入している
ときには、透過する光に青色の低下と光量の低下とが同
時に認められるものと成る。そして、Lambert-Beerの法
則により「溶質の吸光度はその濃度と液層の厚さに比例
する」ものであるので、前記透明容器11の形状を同一
とすれば、吸光度は濃度に比例するものとなり、CCD
カメラ3からの出力も濃度に対応するものとなる。
That is, when chyle is mixed in the test body 10, a decrease in blue color and a decrease in light amount are simultaneously recognized in transmitted light. Then, according to Lambert-Beer's law, "the absorbance of the solute is proportional to its concentration and the thickness of the liquid layer", so if the shape of the transparent container 11 is the same, the absorbance will be proportional to the concentration. , CCD
The output from the camera 3 also corresponds to the density.

【0016】従って、逆に検査に支障を生じない上限限
界の濃度の乳びが混和された試料を予めに用意し、この
試料を透明容器11中に入れた状態で透過した光に感応
したCCDカメラ3の処理回路4を介する出力を記憶さ
せれば、乳び濃度に対する基準値が得られるものとな
り、判定回路5は前記した基準値に対して判定を行えば
良いものとなる。
Therefore, on the contrary, a sample mixed with chyle at the upper limit concentration which does not interfere with the inspection is prepared in advance, and the sample is placed in the transparent container 11 and the CCD sensitive to the transmitted light. If the output from the processing circuit 4 of the camera 3 is stored, a reference value for the chyle concentration can be obtained, and the determination circuit 5 only needs to make a determination based on the reference value.

【0017】図4はビリルビンにおける波長吸収特性B
であり、波長450nmに最大値を有し略350〜520
nmの範囲を有する単峰型の吸収特性を有している。この
ことは、透過光としてはオレンジ色寄りの赤色となり、
CCDカメラ3の処理回路4を介する出力もこれに対応
するものとなり、上記乳びの場合と同様にして濃度に対
する基準値が得られるものとなる。
FIG. 4 shows a wavelength absorption characteristic B of bilirubin.
And has a maximum value at a wavelength of 450 nm and is approximately 350 to 520.
It has a single-peak absorption characteristic having a range of nm. This means that the transmitted light will be reddish near orange,
The output through the processing circuit 4 of the CCD camera 3 also corresponds to this, and a reference value for the density can be obtained in the same manner as in the case of chyle.

【0018】図5は溶血ヘモグロビンにおける波長吸収
特性Hであり、この溶血ヘモグロビンの場合、略420
nm、略540nm、略575nmの3個所にピークを有する
3峰型で、略420nmが最大である特性を示すものであ
る。よって、透過光は前記したビリルビンよりも赤色寄
りであり、CCDカメラ3の処理回路4を介する出力も
これに対応するものとなり、上記乳び、ビリルビンの場
合と同様にして濃度に対する基準値が得られるものとな
る。
FIG. 5 shows the wavelength absorption characteristic H of hemolyzed hemoglobin. In the case of this hemolyzed hemoglobin, approximately 420
It is a three-peak type having peaks at three positions of nm, approximately 540 nm, and approximately 575 nm, and shows a characteristic where the maximum is approximately 420 nm. Therefore, the transmitted light is closer to red than the above-mentioned bilirubin, and the output of the CCD camera 3 through the processing circuit 4 also corresponds to this, and the reference value for the density is obtained in the same manner as in the case of chyle and bilirubin. Will be

【0019】以上は本発明の予備選別装置1の各不純物
(乳び、溶血ヘモグロビン、ビリルビン)に対する濃度
測定の原理であり、現実には2種以上の不純物が混入し
ている事態も当然に予想されるものとなる。しかしなが
ら、本発明の予備選別装置1においては、上記の説明で
も明らかなように基準試料が有れば限界値(基準値)の
設定が可能である。
The above is the principle of the concentration measurement for each impurity (chyle, hemolyzed hemoglobin, bilirubin) of the preselection apparatus 1 of the present invention. In reality, it is naturally expected that two or more kinds of impurities are mixed. Will be done. However, in the preliminary sorting apparatus 1 of the present invention, as is clear from the above description, it is possible to set a limit value (reference value) if there is a reference sample.

【0020】よって、現在、検査現場において練達の臨
床検査技師により目視で行われ、限界とされている検査
体10をCCDカメラ3と処理回路4とで読み取り、こ
の値をもって基準値として設定すれば、その練達の技が
予備選別装置1内に保持されるものとなり、後は全くに
無経験の者であっても表示器6の表示を監視していれば
足りるものとなる。
Therefore, the subject 10 which is currently visually inspected at the examination site by a skilled clinical laboratory technician, and which is regarded as a limit, is read by the CCD camera 3 and the processing circuit 4, and this value is set as a reference value. Then, the skill of the master is held in the preliminary selection device 1, and it is sufficient for even a completely inexperienced person to monitor the display on the display 6.

【0021】また、本発明の予備選別装置1においては
安定性にも優れるものである。これは予備選別装置1が
上記にも説明したように二値化を行うときの基準値とし
て、透明容器11に例えば純水を満たしたものなど無色
の検査体を計測し、CCDカメラ3のR、G,B三原色
それぞれに対する最大値を求める構成としているからで
ある。
Further, the pre-sorting device 1 of the present invention is also excellent in stability. As a reference value when the preselection apparatus 1 performs binarization as described above, a colorless test object such as a transparent container 11 filled with pure water is measured, and the R of the CCD camera 3 is measured. , G, and B primary colors.

【0022】即ち、この行程はCCDカメラ3の較正で
あるが、その較正値は透明容器11の着色、透過率や光
源2の色温度、輝度などを含み行われるものであるの
で、上記の較正を定期的に行うものとすれば、例えば光
源2が経時変化を生じるものであっても、その経時変化
は較正の度ごとにそれらは補正され、計測精度に影響を
及ぼさないものとなる。
That is, this process is a calibration of the CCD camera 3. The calibration values include the coloring of the transparent container 11, the transmittance, the color temperature of the light source 2, the luminance, and the like. Is performed periodically, for example, even if the light source 2 causes a temporal change, the temporal change is corrected for each calibration and does not affect the measurement accuracy.

【0023】更に言えば、本発明の予備選別装置1は、
上記の説明でも明らかなようにRGB各色を8ビットス
ケールで認識したときには、1677万色の識別が可能
であるので、血液検査の項目によっては予備選別のみな
らず本検査も行える可能性がある。そして、このような
場合には、前記判定装置5および表示器6に適宜な改良
を加えれば良いものである。
Furthermore, the preliminary screening device 1 according to the present invention comprises:
As is apparent from the above description, when each of the RGB colors is recognized on an 8-bit scale, 16.770,000 colors can be identified. Therefore, depending on the items of the blood test, not only the preliminary screening but also the main test may be performed. In such a case, the determination device 5 and the display 6 may be appropriately improved.

【0024】尚、本発明の実際の実施にあたっては、既
に、工業用、写真撮影用などとして、本発明のCCDカ
メラ3に相当する、レンズおよびRGB三原色のCCD
素子と、本発明の処理回路4に相当する、適宜精度の二
値化を行う出力回路とが一体化されたものが市場に供給
されているので、それらを流用し本発明の予備選別装置
1を形成することは自在である。
In the actual implementation of the present invention, a lens and a CCD of three primary colors of RGB corresponding to the CCD camera 3 of the present invention have already been used for industrial use, photography and the like.
Since a device in which an element and an output circuit corresponding to the processing circuit 4 of the present invention and which appropriately performs binarization with accuracy are integrated is supplied to the market, these are diverted and the preselection device 1 of the present invention is used. Can be freely formed.

【0025】[0025]

【発明の効果】以上に説明したように本発明により、少
なくとも可視光範囲の波長を放射する光源と、前記光源
から放射され前記血液検査体を透過した光を入射させる
RGB三原色のCCDカメラと、前記CCDカメラの出
力をそれぞれの原色ごとに要求される精度に応じる適宜
ビットスケールに数値化する処理回路と、前記処理回路
の出力により当該の血液検査体の検査の可否を判定する
判定回路とから成る血液検査体の予備選別装置としたこ
とで、第一には、従来は目視で行われ判定には高度の経
験や相当の判断力などを必要とされていたものを、全く
に不要として単純化し検査人員の低減を可能にするな
ど、この種の分析検査の効率向上に極めて優れた効果を
奏するものである。
As described above, according to the present invention, a light source emitting at least a wavelength in the visible light range, a RGB primary color CCD camera for emitting light emitted from the light source and transmitted through the blood test object, A processing circuit for converting the output of the CCD camera into an appropriate bit scale corresponding to the accuracy required for each primary color, and a determination circuit for determining whether or not the blood test body can be tested based on the output of the processing circuit. First of all, the pre-selection device for blood test specimens consists of a device that was previously visually inspected and required a high degree of experience and considerable judgment, etc. It is extremely effective in improving the efficiency of this type of analytical inspection, for example, by reducing the number of inspection personnel.

【0026】また第二には、判定が例えば略1677万
色の識別が可能であるCCDカメラの出力により行われ
るものであり、且つ、CCDカメラは光源を含めて簡便
に較正が可能であるので、判別精度が高く且つその精度
の維持が容易であり、よって、判定精度不足あるいは判
定のブレなどにより無用の再採血や検査不能品の混入な
どが生じるのを防止して、この種の分析検査の信頼性の
向上に極めて優れた効果を奏するものである。
Second, the determination is made based on the output of a CCD camera capable of identifying approximately 16.770,000 colors, and the CCD camera can be easily calibrated, including the light source. In addition, the accuracy of determination is high and it is easy to maintain the accuracy. Therefore, it is possible to prevent unnecessary blood recollection or mixing of untestable products due to insufficient determination accuracy or misalignment of the determination, and this type of analysis test is performed. Has an extremely excellent effect on the improvement of the reliability.

【図面の簡単な説明】[Brief description of the drawings]

【図1】 本発明に係る血液検査体の予備選別装置の実
施形態を略示的に示す説明図である。
FIG. 1 is an explanatory view schematically showing an embodiment of a preselection apparatus for a blood test object according to the present invention.

【図2】 本発明に係る血液検査体の予備選別装置の動
作原理を模式的に示す説明図である。
FIG. 2 is an explanatory view schematically showing the operation principle of the preselection apparatus for a blood test object according to the present invention.

【図3】 本発明に係る予備選別装置の検出対象の1で
ある乳びの波長吸収特性を示すグラフである。
FIG. 3 is a graph showing the wavelength absorption characteristics of chyle, which is one of the detection targets of the preliminary selection device according to the present invention.

【図4】 同じく本発明に係る予備選別装置の検出対象
の1であるビリルビンの波長吸収特性を示すグラフであ
る。
FIG. 4 is a graph showing the wavelength absorption characteristics of bilirubin, which is one of the detection targets of the preselection apparatus according to the present invention.

【図5】 同じく本発明に係る予備選別装置の検出対象
の1である溶血ヘモグロビンの波長吸収特性を示すグラ
フである。
FIG. 5 is also a graph showing the wavelength absorption characteristics of hemolyzed hemoglobin, which is one of the detection targets of the preliminary selection device according to the present invention.

【符号の説明】[Explanation of symbols]

1……予備選別装置 2……光源 3……CCDカメラ 4……処理回路 5……判定回路 6……表示器 10……検査体 11……透明容器 N……乳びの波長吸収特性 B……ビリルビンの波長吸収特性 H……溶血ヘモグロビンの波長吸収特性 DESCRIPTION OF SYMBOLS 1 ... Preliminary sorting apparatus 2 ... Light source 3 ... CCD camera 4 ... Processing circuit 5 ... Judgment circuit 6 ... Display 10 ... Inspection body 11 ... Transparent container N ... Wavelength absorption characteristic of chyle B …… Wavelength absorption characteristics of bilirubin H …… Wavelength absorption characteristics of hemolyzed hemoglobin

───────────────────────────────────────────────────── フロントページの続き Fターム(参考) 2G020 AA08 DA05 DA13 DA34 DA62 DA66 2G045 AA01 AA25 CA25 FA19 FA26 FA29 JA01 JA07 2G059 AA01 BB13 CC16 CC18 EE01 EE13 HH01 HH02 HH03 JJ01 KK04 MM05 NN01  ──────────────────────────────────────────────────続 き Continued on the front page F term (reference) 2G020 AA08 DA05 DA13 DA34 DA62 DA66 2G045 AA01 AA25 CA25 FA19 FA26 FA29 JA01 JA07 2G059 AA01 BB13 CC16 CC18 EE01 EE13 HH01 HH02 HH03 JJ01 KK04 MM05 NN01

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 血液の分析を行うに先立ち精度を損なう
混和物質が混入する血液検査体を排除するための予備選
別装置であって、前記予備選別装置は、少なくとも可視
光範囲の波長を放射する光源と、前記光源から放射され
前記血液検査体を透過した光を入射させるRGB三原色
のCCDカメラと、前記CCDカメラの出力をそれぞれ
の原色ごとに要求される精度に応じる適宜ビットスケー
ルに数値化する処理回路と、前記処理回路の出力により
当該の血液検査体の検査の可否を判定する判定回路とか
ら成ることを特徴とする血液検査体の予備選別装置。
1. A pre-sorting device for eliminating a blood test body mixed with a miscible substance which impairs accuracy prior to performing blood analysis, wherein said pre-sorting device emits at least a wavelength in a visible light range. A light source, a CCD camera of three primary colors of RGB for receiving light emitted from the light source and transmitted through the blood test object, and digitizing the output of the CCD camera to an appropriate bit scale according to the accuracy required for each primary color A preliminary test apparatus for a blood test object, comprising: a processing circuit; and a determination circuit for determining whether or not the blood test object can be tested based on an output of the processing circuit.
JP11028906A 1999-02-05 1999-02-05 Preliminary screening device of blood test body Pending JP2000227399A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11028906A JP2000227399A (en) 1999-02-05 1999-02-05 Preliminary screening device of blood test body

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11028906A JP2000227399A (en) 1999-02-05 1999-02-05 Preliminary screening device of blood test body

Publications (1)

Publication Number Publication Date
JP2000227399A true JP2000227399A (en) 2000-08-15

Family

ID=12261460

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11028906A Pending JP2000227399A (en) 1999-02-05 1999-02-05 Preliminary screening device of blood test body

Country Status (1)

Country Link
JP (1) JP2000227399A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007263907A (en) * 2006-03-30 2007-10-11 Sysmex Corp Blood coagulation time measuring device
EP2120038A2 (en) * 2008-05-14 2009-11-18 Grifols, S.A. Microtube reader device for the analysis of blood samples
KR101177537B1 (en) 2012-02-09 2012-08-28 (주)싸이젠텍 Ingredient analysing apparatus
JP2013501937A (en) * 2009-08-13 2013-01-17 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド Method and apparatus for determining interfering substances and physical dimensions in liquid samples and containers analyzed by a clinical analyzer
CN103033513A (en) * 2011-09-28 2013-04-10 蓝伊精机株式会社 Test preprocessing apparatus, test preprocessing method, and specimen processing apparatus
WO2015072358A1 (en) * 2013-11-12 2015-05-21 株式会社日立ハイテクノロジーズ Analyte testing automation system, biological sample check module, and biological sample check method
JP2017151110A (en) * 2017-03-06 2017-08-31 ツェー アー カズィゾ アーゲーC A Casyso Ag Blood testing system and method

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007263907A (en) * 2006-03-30 2007-10-11 Sysmex Corp Blood coagulation time measuring device
EP2120038A2 (en) * 2008-05-14 2009-11-18 Grifols, S.A. Microtube reader device for the analysis of blood samples
JP2009276349A (en) * 2008-05-14 2009-11-26 Grifols Sa Microtube reader device for analysis of blood sample and method for reading microtube
EP2120038A3 (en) * 2008-05-14 2012-08-08 Grifols, S.A. Microtube reader device for the analysis of blood samples
JP2013501937A (en) * 2009-08-13 2013-01-17 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド Method and apparatus for determining interfering substances and physical dimensions in liquid samples and containers analyzed by a clinical analyzer
US9322761B2 (en) 2009-08-13 2016-04-26 Siemens Healthcare Diagnostics Inc. Methods and apparatus for ascertaining interferents and physical dimensions in liquid samples and containers to be analyzed by a clinical analyzer
US9261449B2 (en) 2011-09-28 2016-02-16 Aoi Seiki Co., Ltd. Test preprocessing apparatus, test preprocessing method, and specimen processing apparatus
CN103033513A (en) * 2011-09-28 2013-04-10 蓝伊精机株式会社 Test preprocessing apparatus, test preprocessing method, and specimen processing apparatus
EP2574907A3 (en) * 2011-09-28 2013-04-10 Aoi Seiki Co., Ltd Test preprocessing apparatus, test preprocessing method, amd specimen processing apparatus
CN103033513B (en) * 2011-09-28 2015-03-25 蓝伊精机株式会社 Test preprocessing apparatus, test preprocessing method, and specimen processing apparatus
KR101177537B1 (en) 2012-02-09 2012-08-28 (주)싸이젠텍 Ingredient analysing apparatus
WO2015072358A1 (en) * 2013-11-12 2015-05-21 株式会社日立ハイテクノロジーズ Analyte testing automation system, biological sample check module, and biological sample check method
CN105637370A (en) * 2013-11-12 2016-06-01 株式会社日立高新技术 Analyte testing automation system, biological sample check module, and biological sample check method
JPWO2015072358A1 (en) * 2013-11-12 2017-03-16 株式会社日立ハイテクノロジーズ Specimen automation system, biological sample check module, and biological sample check method
US10247743B2 (en) 2013-11-12 2019-04-02 Hitachi High-Technologies Corporation Analyte testing automation system, biological sample check module, and biological sample check method
JP2017151110A (en) * 2017-03-06 2017-08-31 ツェー アー カズィゾ アーゲーC A Casyso Ag Blood testing system and method

Similar Documents

Publication Publication Date Title
EP3311144B1 (en) Colour measurement of gemstones
CN105899935B (en) Test piece and the method for reading test piece
US20150171236A1 (en) Fish eye lens analyzer
JP6813676B2 (en) Total protein measurement using whole blood index measurement
JP2008541179A (en) Separation of spectral or color superimposed image contributions in multicolor images, especially microscope multicolor transmission images
CN108776107B (en) Spectrum analysis method for replacing visible spectrophotometer
JP2001264327A (en) Colorimetric strip generating visual effect
JP7250925B2 (en) Method and apparatus for puffy-coat imaging
EP3431966B1 (en) Display device for photometric analyzer
US20190025208A1 (en) Fluorescence spectrophotometer and fluorescence spectrometry and imaging method
JP2003502631A (en) Method and apparatus for testing biologically derived fluids
JP2000227399A (en) Preliminary screening device of blood test body
CA3041973A1 (en) Cell measurement method
KR101706702B1 (en) Method for glucose concentration detection
EP2691759B1 (en) High flux collimated illuminator and method of uniform field illumination
Schafer The colour of the human skull
JP2714542B2 (en) Titration emulation system and method for titrating a sample
JPH0735744A (en) Analytic method for urine
JPH05223729A (en) Method and device for judging degree of deterioration of lubricating oil
JPH1073534A (en) Equipment for determining color developing matter
US4951097A (en) Method and apparatus for bone histomorphometry
US10514334B2 (en) Cell measurement method
JPH02280033A (en) Colorimetry inspecting device
JP2901642B2 (en) Method for determining presence or absence of antigen or antibody reaction by automatic image determination and automatic image determination device
Zhbanova et al. Information Technologies in Colorimetric Laboratory Research

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20040330